Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-01-04
2005-01-04
Davis, Brian (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C548S494000, C549S292000, C560S248000, C560S256000
Reexamination Certificate
active
06838566
ABSTRACT:
Lovastatin, pravastatin, simvastatin, mevastatin, atorvastatin, and derivatives and analogs thereof are known as HMG-CoA reductase inhibitors and are used as antihypercholesterolemic agents. The majority of them are produced by fermentation using microorganisms of different species identified as species belonging to Aspergillus, Monascus, Nocardia, Amycolatopsis, Mucor or Penicillium genus, some are obtained by treating the fermentation products using the methods of chemical synthesis or they are the products of total chemical synthesis. The present invention relates to the new amine salts of HMG-CoA reductase inhibitors, the preparation thereof, the preparation of pure HMG-CoA reductase inhibitors via amine salts thereof, use of the amine salts of HMG-CoA reductase inhibitors in the process for semisynthetic preparation of HMG-CoA reductase inhibitors, use of the amine salts of HMG-CoA reductase inhibitors in the process for biotechnological modification of HMG-CoA reductase inhibitors as well as the conversion of the amine salts of HMG-CoA reductase inhibitors into the pharmaceutically acceptable salts of the HMG-CoA reductase inhibitors and the conversion of the amine salts of HMG-CoA reductase inhibitors into the HMG-CoA reductase inhibitors in the lactone form.
REFERENCES:
patent: 4319039 (1982-03-01), Albers-Schonberg
patent: 4342767 (1982-08-01), Albers-Schonberg
patent: 4346227 (1982-08-01), Terahara et al.
patent: 5223415 (1993-06-01), Conder et al.
patent: 5356896 (1994-10-01), Kabadi et al.
patent: 5403860 (1995-04-01), Kurabayashi et al.
patent: 5763646 (1998-06-01), Kumar et al.
patent: 5763653 (1998-06-01), Khanna et al.
patent: 0 065 835 (1985-11-01), None
patent: 0 456 214 (1991-11-01), None
patent: 2 055 100 (1981-02-01), None
patent: 217629 (1992-11-01), None
patent: 221849 (1992-11-01), None
patent: 57-123140 (1982-07-01), None
patent: 57-123140 (1982-07-01), None
Cohen & Pontani, Lieberman & Pavane
Davis Brian
LEK Pharmaceuticals d.d.
LandOfFree
Salts of HMG-CoA reductase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Salts of HMG-CoA reductase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Salts of HMG-CoA reductase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3420321